摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2'-deoxycytidyl-(3'->5'){2'-deoxyguanosine-3'-[phosphoro-(2''-O-hydroxyethyl)quinoxaline]} | 148896-41-7

中文名称
——
中文别名
——
英文名称
2'-deoxycytidyl-(3'->5'){2'-deoxyguanosine-3'-[phosphoro-(2''-O-hydroxyethyl)quinoxaline]}
英文别名
——
2'-deoxycytidyl-(3'->5'){2'-deoxyguanosine-3'-[phosphoro-(2''-O-hydroxyethyl)quinoxaline]}化学式
CAS
148896-41-7
化学式
C29H34N10O13P2
mdl
——
分子量
792.596
InChiKey
DZQBHDOCTLZLIK-ILWPDHKNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.97±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    54.0
  • 可旋转键数:
    14.0
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    326.49
  • 氢给体数:
    6.0
  • 氢受体数:
    20.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2'-deoxycytidyl-(3'->5'){2'-deoxyguanosine-3'-[phosphoro-(2''-O-hydroxyethyl)quinoxaline]}亚精胺乙二胺四乙酸 、 polynucleotide kinase 、 <γ-32P>ATP 、 三羟甲基氨基甲烷盐酸盐 、 magnesium chloride 作用下, 反应 0.5h, 生成
    参考文献:
    名称:
    On the chemistry of RNA degradation by Fe·bleomycin
    摘要:
    The chemistry of RNA degradation by Fe bleomycin was studied using two RNA substrates that are modified efficiently at a small number of sites by the antitumor antibiotic. Cleavage of a tRNA(His) precursor transcript by Fe(II).BLM A(2) was shown to require O-2; cleavage was also observed when the same substrate was treated with Fe(III).BLM A(2) + H2O2. Consistent with earlier observations made for DNA, the extent of tRNA(His) precursor cleavage was greater for Fe(II).BLM A(5), than for Fe(II).BLM A(2); the least cleavage was obtained using Fe(II).BLM demethyl A(2). By the use of a P-32 end labeled tRNA precursor transcript that was also H-3 labeled within the uracil moieties, it was shown that release of uracil was nearly stoichiometric with tRNA strand scission by Fe(II).BLM A(2). Nonetheless, treatment of the tRNA(His) with hydrazine following BLM-mediated cleavage indicated formation of a new product that must have derived from a BLM-induced lesion. Also employed far characterization of BLM cleavage of RNA were the octanucleotides CGCTAGCG, C-3-ribo-CGCTAGCG and C-3-ara-CGCTAGCG. Analysis of the products of cleavage indicates that Fe . BLM is capable of mediating cleavage by abstraction of a H atom either from C-4'H or C-1'H of the chimeric oligonucleotides. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0968-0896(97)00038-2
  • 作为产物:
    描述:
    5'-(4,4'-dimethoxytrityl)-N2-isobutyryl-2'-deoxyguanosine-3'-[H-phosphono-(2''-O-hydroxyethyl)quinoxaline] 在 吡啶ammonium hydroxide溶剂黄146三氟乙酸三甲基乙酸 作用下, 以 四氢呋喃氯仿 为溶剂, 反应 16.17h, 生成 2'-deoxycytidyl-(3'->5'){2'-deoxyguanosine-3'-[phosphoro-(2''-O-hydroxyethyl)quinoxaline]}
    参考文献:
    名称:
    On the chemistry of RNA degradation by Fe·bleomycin
    摘要:
    The chemistry of RNA degradation by Fe bleomycin was studied using two RNA substrates that are modified efficiently at a small number of sites by the antitumor antibiotic. Cleavage of a tRNA(His) precursor transcript by Fe(II).BLM A(2) was shown to require O-2; cleavage was also observed when the same substrate was treated with Fe(III).BLM A(2) + H2O2. Consistent with earlier observations made for DNA, the extent of tRNA(His) precursor cleavage was greater for Fe(II).BLM A(5), than for Fe(II).BLM A(2); the least cleavage was obtained using Fe(II).BLM demethyl A(2). By the use of a P-32 end labeled tRNA precursor transcript that was also H-3 labeled within the uracil moieties, it was shown that release of uracil was nearly stoichiometric with tRNA strand scission by Fe(II).BLM A(2). Nonetheless, treatment of the tRNA(His) with hydrazine following BLM-mediated cleavage indicated formation of a new product that must have derived from a BLM-induced lesion. Also employed far characterization of BLM cleavage of RNA were the octanucleotides CGCTAGCG, C-3-ribo-CGCTAGCG and C-3-ara-CGCTAGCG. Analysis of the products of cleavage indicates that Fe . BLM is capable of mediating cleavage by abstraction of a H atom either from C-4'H or C-1'H of the chimeric oligonucleotides. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0968-0896(97)00038-2
点击查看最新优质反应信息

同类化合物

鸟苷酰-3'-5'-胞苷铵盐 鸟苷酰-(3'-5')-尿苷 鸟苷酰(3'-5')尿苷3'-单磷酸酯 腺苷酰基-(3,’5’)-胞苷 腺苷酰-(3'→5')-胞苷 腺苷酰-(3'-5')-尿苷3'-单磷酸酯 腺苷基3'-5'-腺苷铵盐 脱氧鸟苷酰-(3'-5')-鸟苷 脱氧鸟苷酰-(3'-5')-脱氧腺苷 脱氧腺苷酰-(3'-5')-脱氧鸟苷 脱氧胞苷酰-(3'-5')-脱氧鸟苷 胸苷酰-(3'-5')脱氧尿苷 胸苷酰-(3'-5')-3'-胸苷酸 胸苷酰-(3'-5')-2'-脱氧-5-氟尿苷 胸苷酰(3'->5')胸苷铵盐 胸苷基(3'5')-2'-脱氧腺苷铵盐 胞苷酰-(5'->3')-鸟苷 胞苷酰-(3',5')-鸟苷 胞苷酰(3'->5')尿苷铵盐 聚(2-氨基脱氧腺嘌呤基-5-碘脱氧尿苷酸) 聚(2-氨基脱氧腺嘌呤基-5-溴脱氧尿苷酸) 环二腺苷酸 尿酸氧化酶 尿苷酰基-(3',5')-尿苷 二(3',5')-环二鸟苷酸 乙基3,4,5-三[[(6-重氮基-5,6-二氢-5-羰基-1-萘基)磺基基]氧代]苯酸酯 [5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基][5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲基[羟基-[2,3,4-三羟基-5-(7-甲基-2,4,8-三氧代-1H-嘧啶并[4,5-b]喹啉-10-基)戊氧基]磷酰]磷酸氢酯 [5-(4-氨基-2-氧代-嘧啶-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基[5-(4-氨基-2-氧代-嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(6-氨基嘌呤-9-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,5R)-5-(2,4-二氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-3-羟基四氢呋喃-2-基]甲基 [(2R,3S,5R)-2-(羟基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1-基)-2-(膦酰氧基甲基)四氢呋喃-3-基][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 [(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]磷酸氢酯 N-羟基联苯基-4,4'-二胺 N-{1-[(2-氨基乙基)硫烷基]丙烷-2-基}-6-甲氧基-4-甲基-5-[3-(三氟甲基)苯氧基]喹啉-8-胺 8-氯-黄素腺嘌呤二核苷酸 8-巯基-黄素腺嘌呤二核苷酸 5-脱氮黄素腺嘌呤二核苷酸 5'-磷酰胸苷酰(3'-5')脱氧腺苷 5'-O-胸苷酰 3'-O-(2'-脱氧腺苷)硫代磷酸酯 2'-脱氧鸟苷酰-(5'-3')-2'-脱氧-5'-鸟苷酸 2'-脱氧鸟苷酰-(3'-5')-2'-脱氧胞苷 2'-脱氧鸟苷酰(3'->5')-2'-脱氧鸟苷钠盐 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷 2'-脱氧胞苷酰-(3'-5')-胸苷 2'-脱氧胞啶基(3'->5')-2'-脱氧鸟苷铵盐 1H-苯并三唑,硫酸酯(1:1) 1-(2-脱氧-5-O-磷羧基五呋喃糖基)-5-[(1E)-3-{[5-(2-羰基六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰基]氨基}丙-1-烯-1-基]嘧啶-2,4(1H,3H)-二酮